Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | CCR2 | P41597 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17147338 | 0.91 | CTSK (0.35) | CTSKCCR2CYP1A2 | |
| SCHEMBL13767051 | 0.90 | CTSK (0.40) | CTSKCCR2TP53PKMHTT | |
| SCHEMBL13095730 | 0.88 | TP53 (0.43) | CTSKCCR2TP53PKMHTT | |
| SCHEMBL14451346 | 0.86 | SHBG (0.33) | HTTPOLBEPHX1 | |
| SCHEMBL13239386 | 0.82 | TSHR (0.37) | CTSKTSHREPHX1NAAA | |
| SCHEMBL12152925 | 0.82 | EPHX1 (0.35) | CTSKTSHRMAPK1EPHX1 | |
| SCHEMBL9607899 | 0.82 | SHBG (0.35) | CTSKEPHX1 | |
| SCHEMBL13239393 | 0.80 | PKM (0.37) | CTSKCCR2TP53PKMHTT | |
| SCHEMBL15128248 | 0.80 | CTSK (0.39) | CTSKCCR2TP53PKMHTT | |
| SCHEMBL13701727 | 0.79 | MEN1 (0.38) | CTSKCCR2TP53PKMHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230340328-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-26 | — | — | US | disclosed |
| US-20230272282-A1 | LC MIXTURES WITH NEGATIVE DELTA EPSILONCONTAINING CC-4-V1 AND COB(S)-N-OM | MERCK PATENT GMBH (DE) | 2023-08-31 | — | — | US | disclosed |
| US-20230183571-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-06-15 | — | — | US | disclosed |
| US-11667845-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2023-06-06 | — | — | US | disclosed |
| US-20180208848-A1 | LIQUID CRYSTALLINE MEDIA HAVING HOMEOTROPIC ALIGNMENT | MERCK PATENT GMBH (DE) | 2018-07-26 | — | — | US | disclosed |
| EP-3235894-A2 | LIQUID CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2017-10-25 | — | — | EP | disclosed |
| EP-2837671-B1 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2017-10-25 | — | — | EP | disclosed |
| EP-3228681-A1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME | Merck Patent GmbH (DE) | 2017-10-11 | — | — | EP | disclosed |
| WO-2017162716-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-09-28 | — | — | WO | disclosed |
| WO-2017162717-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-09-28 | — | — | WO | disclosed |
| EP-2248872-A2 | Liquid crystalline medium | Merck Patent GmbH (DE) | 2010-11-10 | — | — | EP | disclosed |
| EP-2208774-A2 | Liquid crystalline medium | Merck Patent GmbH (DE) | 2010-07-21 | — | — | EP | disclosed |
| US-7754103-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2010-07-13 | — | — | US | disclosed |
| EP-2199362-A2 | Liquid crystalline medium | Merck Patent GmbH (DE) | 2010-06-23 | — | — | EP | disclosed |
| EP-2182046-A1 | Liquid-crystalline medium and liquid crystal display | Merck Patent GmbH (DE) | 2010-05-05 | — | — | EP | disclosed |
| US-20090194738-A1 | Liquid-crystalline medium | MANABE ATSUTAKA | 2009-08-06 | — | — | US | disclosed |
| EP-1658352-B1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2008-04-02 | — | — | EP | disclosed |
| WO-2008025533-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2008-03-06 | — | — | WO | disclosed |
| EP-1832643-A1 | Liquid crystalline medium and liquid-crystal display | Merck Patent GmbH (DE) | 2007-09-12 | — | — | EP | disclosed |
| US-7201951-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2007-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667845-B2 | Liquid crystalline medium | NEFM, CCNI, MYT1 | CTSK 1034/4885CCR2 1180/4885TP53 1756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.